| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 1129-ER-01M | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF1129-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF1768-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB4360-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-29624SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70653 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB11291-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF5176-SP | |||
![Western Blot: ErbB2/HER2 Antibody [NBP2-29624] - Western blot analysis of ErbB2/HER2 in SKOV3 cell lysate.](http://images.novusbio.com/fullsize/ErbB2-HER2-Antibody-Western-Blot-NBP2-29624-img0001.jpg "Western Blot: ErbB2/HER2 Antibody [NBP2-29624] - Western blot analysis of ErbB2/HER2 in SKOV3 cell lysate.")
![Immunohistochemistry-Paraffin: ErbB2/Her2 Antibody [NBP2-29624] - IHC analysis of a formalin-fixed paraffin-embedded (FFPE) human breast carcinoma tissue section using 1:50 dilution of ErbB2/HER2 antibody (NBP2-29624) on a Bond Rx autostainer (Leica Biosystems). The assay involved 20 minutes of heat induced antigen retrieval (HIER) with 10mM sodium citrate buffer (pH 6.0) and endogenous peroxidase quenching using peroxide block. The sections were incubated with primary antibody for 30 minutes. Bond Polymer Refine Detection (Leica Biosystems) and DAB were used for signal detection which followed counterstaining with hematoxylin. Whole slide scanning and capturing of representative images (20X) were performed using Aperio AT2 (Leica Biosystems). This ErbB3 antibody generated a diffused cytoplasmic with some membrane and nuclear staining in the cancer cells, endothelial cells as well as in the tumor stromal cells. The cells in the cores of some tumor areas were negative for ErbB2.](http://images.novusbio.com/fullsize/ErbB2-Her2-Antibody-Immunohistochemistry-Paraffin-NBP2-29624-img0003.jpg)
![Immunohistochemistry-Paraffin: ErbB2/Her2 Antibody [NBP2-29624] - IHC analysis of a formalin-fixed paraffin-embedded (FFPE) human breast carcinoma tissue section using 1:50 dilution of ErbB2/HER2 antibody (NBP2-29624) on a Bond Rx autostainer (Leica Biosystems). The assay involved 20 minutes of heat induced antigen retrieval (HIER) with 10mM sodium citrate buffer (pH 6.0) and endogenous peroxidase quenching using peroxide block. The sections were incubated with primary antibody for 30 minutes. Bond Polymer Refine Detection (Leica Biosystems) and DAB were used for signal detection which followed counterstaining with hematoxylin. Whole slide scanning and capturing of representative images (20X) were performed using Aperio AT2 (Leica Biosystems). This ErbB2 antibody generated a diffused cytoplasmic with some membrane and nuclear staining in the cancer cells, endothelial cells as well as in the tumor stromal cells. Staining was performed by Histowiz.](http://images.novusbio.com/fullsize/ErbB2-Her2-Antibody-Immunohistochemistry-Paraffin-NBP2-29624-img0002.jpg)
![Western Blot: ErbB2/Her2 [p Tyr1248] Antibody [NB100-81960] - Analysis of extracts from HepG2 cells treated with PMA and MCF cells.](http://images.novusbio.com/fullsize/ErbB2-Her2-[p-Tyr1248]-Antibody-Western-Blot-NB100-81960-img0012.jpg "Western Blot: ErbB2/Her2 [p Tyr1248] Antibody [NB100-81960] - Analysis of extracts from HepG2 cells treated with PMA and MCF cells.")
![Immunohistochemistry-Paraffin: ErbB2/Her2 [p Tyr1248] Antibody [NB100-81960] - Human breast carcinoma tissue.](http://images.novusbio.com/fullsize/ErbB2-Her2-[p-Tyr1248]-Antibody-Immunohistochemistry-Paraffin-NB100-81960-img0011.jpg)
![Immunocytochemistry/Immunofluorescence: ErbB2/Her2 [p Tyr1248] Antibody [NB100-81960] - Staining of methanol-fixed MCF7 cells using HER2 phospho-antibody.](http://images.novusbio.com/fullsize/ErbB2-Her2-[p-Tyr1248]-Antibody-Immunocytochemistry-Immunofluorescence-NB100-81960-img0007.jpg)
![Immunohistochemistry-Paraffin: ErbB2/Her2 [p Tyr1248] Antibody [NB100-81960] - Human lung carcinoma tissue.](http://images.novusbio.com/fullsize/ErbB2-Her2-[p-Tyr1248]-Antibody-Immunohistochemistry-Paraffin-NB100-81960-img0010.jpg)
![Immunohistochemistry-Paraffin: ErbB2/Her2 [p Tyr1248] Antibody [NB100-81960] - Immunohistochemical analysis of paraffin-embedded human breast carcinoma, using NB100-81960. The picture on the right is blocked with the phospho peptide.](http://images.novusbio.com/fullsize/nb100-81960_rabbit-polyclonal-erbb2-her2-p-tyr1248-antibody-23420241446224.jpg)
![<b>Biological Strategies Validation. </b>Western Blot: ErbB2/Her2 [p Tyr1248] Antibody [NB100-81960] - Western blot analysis of lysates from HepG2 cells treated with PMA 125ng/ml 30', using NB100-81960. The lane on the right is blocked with the phospho peptide.](http://images.novusbio.com/fullsize/nb100-81960_rabbit-polyclonal-erbb2-her2-p-tyr1248-antibody-23420241520580.jpg)
![Western Blot: ErbB2/Her2 [p Tyr1248] Antibody [NB100-81960] - Western Blot analysis of 293 cells using NB100-81960 diluted at 1: 1000](http://images.novusbio.com/fullsize/nb100-81960_rabbit-polyclonal-erbb2-her2-p-tyr1248-antibody-23420241545355.jpg)
![<b>Biological Strategies Validation. </b>Western Blot: ErbB2/Her2 [p Tyr1248] Antibody [NB100-81960] - Western blot analysis of lysates from HepG2 cells treated with PMA 125ng/ml 30', using NB100-81960. The lane on the right is blocked with the phospho peptide.](http://images.novusbio.com/fullsize/nb100-81960_rabbit-polyclonal-erbb2-her2-p-tyr1248-antibody-23420241545357.jpg)
![Immunocytochemistry/ Immunofluorescence: ErbB2/Her2 [p Tyr1248] Antibody [NB100-81960] - Mutant ERBB2 cooperates with loss of p53 & leads to papillary GBC in recipient mice. (A) Top: Schematic of human ERBB2, indicating the location of two point mutants (S310F & V777L). Bottom: retroviral vector used to transduce organoids, that had been treated with an sgp53-containing plasmid (px459) to induce loss of p53. (B) Immunofluorescence for ERBB2 (top) & phospho-ERBB2 (bottom) on organoids harboring the indicated genetic alterations. (C) Tumor volumes 36 days after s.c. implantation of the respective organoids into recipient mice. All mice transplanted with sgp53;ERBB2S310F- & sgp53;ERBB2V777L organoids exhibited tumor development, whereas sgp53;empty vector- & sgp53;ERBB2wildtype organoids did not give rise to tumors over a four-month observation period. There was no significant difference in the tumor burden of mice transplanted with sgp53;ERBB2S310F- & sgp53;ERBB2V777L organoids (p = 0.999). (D) Mice transplanted with sgp53;ERBB2S310F- & sgp53;ERBB2V777L organoids reached endpoint criteria with a median survival of 79.5 days & 58.5 days, respectively. (E) H&E & IHC for CK19 & EGFP on tumors generated with sgp53;ERBB2S310- & sgp53;ERBB2V777L organoids. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31795490), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-81960_rabbit-polyclonal-erbb2-her2-p-tyr1248-antibody-310202416284926.jpg)
![Western Blot: ErbB2/Her2 Antibody (OTI4F10) [NBP2-01152] - Analysis of extracts (35ug) from 2 different Human cell lines, dilution (1:500).](http://images.novusbio.com/fullsize/ErbB2-Her2-Antibody-OTI4F10-Western-Blot-NBP2-01152-img0010.jpg "Western Blot: ErbB2/Her2 Antibody (OTI4F10) [NBP2-01152] - Analysis of extracts (35ug) from 2 different Human cell lines, dilution (1:500).")
![Immunocytochemistry/Immunofluorescence: ErbB2/Her2 Antibody (OTI4F10) [NBP2-01152] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY ErbB2/HER2.](http://images.novusbio.com/fullsize/ErbB2-Her2-Antibody-4F10-Immunocytochemistry-Immunofluorescence-NBP2-01152-img0008.jpg)
![Immunohistochemistry-Paraffin: ErbB2/HER2 Antibody (4F10) [NBP2-01152] - Staining of paraffin-embedded Human Kidney tissue using anti-ErbB2/HER2 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/ErbB2-HER2-Antibody-4F10-Immunohistochemistry-Paraffin-NBP2-01152-img0005.jpg)
![Flow Cytometry: ErbB2/HER2 Antibody (4F10) [NBP2-01152] - HEK293T cells transfected with either overexpression plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-ErbB2/HER2 antibody, and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/ErbB2-HER2-Antibody-4F10-Flow-Cytometry-NBP2-01152-img0001.jpg)
![Western Blot: ErbB2/HER2 Antibody (4F10) [NBP2-01152] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ErbB2/HER2 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-ErbB2/HER2.](http://images.novusbio.com/fullsize/ErbB2-HER2-Antibody-4F10-Western-Blot-NBP2-01152-img0002.jpg)
![Western Blot: ErbB2/HER2 Antibody (4F10) [NBP2-01152] - 1: Testis; 2: Uterus; 3: Breast; 4: Brain; 5: Liver; 6: Ovary; 7: Thyroid gland; 8:Colon.](http://images.novusbio.com/fullsize/ErbB2-HER2-Antibody-4F10-Western-Blot-NBP2-01152-img0007.jpg)
![Immunohistochemistry-Paraffin: ErbB2/HER2 Antibody (4F10) [NBP2-01152] - Staining of paraffin-embedded Adenocarcinoma of Human breast tissue using anti-ErbB2/HER2 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/ErbB2-HER2-Antibody-4F10-Immunohistochemistry-Paraffin-NBP2-01152-img0003.jpg)
![Immunohistochemistry-Paraffin: ErbB2/HER2 Antibody (4F10) [NBP2-01152] - Staining of paraffin-embedded Carcinoma of Human pancreas tissue using anti-ErbB2/HER2 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/ErbB2-HER2-Antibody-4F10-Immunohistochemistry-Paraffin-NBP2-01152-img0004.jpg)
![Western Blot: ErbB2/Her2 Antibody [NBP1-84584] - Analysis in human cell line SK-BR-3.](http://images.novusbio.com/fullsize/ErbB2-Her2-Antibody-Western-Blot-NBP1-84584-img0006.jpg "Western Blot: ErbB2/Her2 Antibody [NBP1-84584] - Analysis in human cell line SK-BR-3.")
![Immunocytochemistry/Immunofluorescence: ErbB2/Her2 Antibody [NBP1-84584] - Staining of human cell line MCF7 shows localization to plasma membrane. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/ErbB2-Her2-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-84584-img0008.jpg)
![Immunohistochemistry-Paraffin: ErbB2/Her2 Antibody [NBP1-84584] - Staining of human skeletal muscle shows no positivity in myocytes as expected.](http://images.novusbio.com/fullsize/ErbB2-Her2-Antibody-Immunohistochemistry-Paraffin-NBP1-84584-img0013.jpg)
![Immunohistochemistry-Paraffin: ErbB2/Her2 Antibody [NBP1-84584] - Staining of human breast cancer shows no positivity in tumor cells as expected.](http://images.novusbio.com/fullsize/ErbB2-Her2-Antibody-Immunohistochemistry-Paraffin-NBP1-84584-img0010.jpg)
![Immunohistochemistry-Paraffin: ErbB2/Her2 Antibody [NBP1-84584] - Staining of human breast cancer shows strong membranous positivity in tumor cells.](http://images.novusbio.com/fullsize/ErbB2-Her2-Antibody-Immunohistochemistry-Paraffin-NBP1-84584-img0011.jpg)
![Immunohistochemistry-Paraffin: ErbB2/Her2 Antibody [NBP1-84584] - Staining of human kidney shows weak to moderate granular cytoplasmic positivity in cells in tubules.](http://images.novusbio.com/fullsize/ErbB2-Her2-Antibody-Immunohistochemistry-Paraffin-NBP1-84584-img0012.jpg)
